Laurie D. Stelzer

2020

In 2020, Laurie D. Stelzer earned a total compensation of $171.2K as Former Senior Vice President, Chief Financial Officer at Halozyme Therapeutics, a 92% decrease compared to previous year.

Compensation breakdown

Salary$93,225
Other$77,996
Total$171,221

Stelzer received $93.2K in salary, accounting for 54% of the total pay in 2020.

Stelzer also received $78K in other compensation.

Rankings

In 2020, Laurie D. Stelzer's compensation ranked 12,691st out of 13,090 executives tracked by ExecPay. In other words, Stelzer earned more than 3.0% of executives.

ClassificationRankingPercentile
All
12,691
out of 13,090
3rd
Division
Manufacturing
5,443
out of 5,621
3rd
Major group
Chemicals And Allied Products
2,198
out of 2,254
3rd
Industry group
Drugs
1,910
out of 1,954
2nd
Industry
Biological Products, Except Diagnostic Substances
405
out of 411
2nd

Pay ratio

Laurie D. Stelzer's Pay$171,221
Median Employee's Pay$223,441
Pay Ratio

1

to 1

In 2020, the annual total compensation of Laurie D. Stelzer was $171,221.

The annual total compensation of the median employee at Halozyme Therapeutics was $223,441.

The ratio of Laurie D. Stelzer's pay to the pay of median employee was therefore 1 to one.

Source: SEC filing on March 26, 2021.

Stelzer's colleagues

We found four more compensation records of executives who worked with Laurie D. Stelzer at Halozyme Therapeutics in 2020.

2020

Helen Torley

Halozyme Therapeutics

Chief Executive Officer

2020

Elaine Sun

Halozyme Therapeutics

Chief Financial Officer

2020

Michael LaBarre

Halozyme Therapeutics

Senior Vice President, Chief Technical Officer

2020

Masaru Matsuda

Halozyme Therapeutics

General Counsel

News

You may also like